Lack of birth defects after paternal exposure to lamivudine [2]

Journal of Hepatology

Volumn 36, Issue 4, 2002, Pages 571-

  Trojan, Joerg ^a   Kronenberger, Bernd ^a   Von Wagner, Michael ^a   Zeuzem, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; PEGINTERFERON ALPHA2B; ZIDOVUDINE;

BIRTH DEFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; FETUS MALFORMATION; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; MUTAGENICITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY; ULTRASOUND;

ABNORMALITIES, DRUG-INDUCED; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; PATERNAL EXPOSURE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0036116346     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00008-9     Document Type: Letter

References (4)

1. Management of hepatitis B: 2000. Summary of a workshop
2. Adverse effects and drug interactions of clinical importance with antiviral drugs
3. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
4. Lamivudine therapy for chronic hepatitis B virus infection and pregnancy: A case report